Aptus Pharma Share Price
Free Demat with Zero AMC*
+ Free 1st Year AMC
Summary
The stock has recorded a trading volume of 2,400 shares,. Its Average Traded Price (ATP) is ₹487.06, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 400 @ ₹488.00.
Aptus Pharma has an upper circuit limit of ₹489.60 and a lower circuit limit of ₹470.40. The total value traded stands at ₹11.69 L, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 400. Aptus Pharma also offers a dividend yield of 0%.
Aptus Pharma Share Price Chart
Aptus Pharma Share Key Metrics
Volume
2400.00
Market Cap
836.92 CR
LTQ@LTP
400@488.00
ATP
487.06
Var Margin
100 %
Circuit Range
470.4-489.6
Delivery %
0 %
Value
11.69 L
ASM/GSM
No
Market Lot
400
Aptus Pharma Resistance and Support
Pivot 478.13
Resistance
First Resistance
482.46
Second Resistance
484.93
Third Resistance
489.26
Support
First Support
475.66
Second Support
471.33
Third Support
468.86
Aptus Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-12 | Preferential issue of shares |
| 2026-10-20 | Half Yearly Results |
| 2026-08-17 | A.G.M. |
| 2026-08-08 | Preferential issue of shares |
| 2026-06-12 | Preferential Issue of shares & Others |
| 2026-04-27 | Audited Results |
| 2026-03-24 | Bonus issue & Others |
| 2025-11-10 | Half Yearly Results |
| Bonus Date | Record Date | |
|---|---|---|
| 2026-03-24 | 2026-05-12 | View More |
Aptus Pharma News
Aptus Pharma Ltd - 544529 - Board Meeting Outcome for Outcome Of Board Meeting - Allotment Of Equity Shares On Preferential Basis Under Regulation 30 Of SEBI LODR Regulations, 2015
Aptus Pharma board approved a preferential allotment of 15.97 lakh equity shares at an issue price of ₹280 per share, aggregating to ₹44.73 crores. The shares were allotted to 188 allottees on a private placement basis, leading to an increase in the paid-up equity share capital to ₹18.75 crores.
Nov 12 2026 12:47:11
Aptus Pharma Ltd - 544529 - Board Meeting Intimation for Intimation Of Board Meeting For Allotment Of Equity Shares On Preferential Basis
Aptus Pharma board of directors will meet on 12 November 2026 to consider and approve the allotment of equity shares on a preferential basis. The allotment follows shareholder approval received in September 2026 and BSE in-principle approval.
Nov 06 2026 11:45:38
Aptus Pharma Ltd - 544529 - Receipt Of In-Principle Approval For Preferential Issue
Aptus Pharma has received in-principle approval from BSE for its proposed preferential issue. The company will issue 15,99,270 equity shares at a price of Rs.280 per share to promoters and non-promoters.
Oct 30 2026 19:31:38
Aptus Pharma Ltd - 544529 - Board Meeting Outcome for Outcome Of Board Meeting Held On 20.10.2026 Along With Financial Results For Half Year Ended 30Th September, 2026
Aptus Pharma announced its H1 FY27 results, reporting a revenue of ₹48.92 crore (nearly 2x YoY growth) and a net profit of ₹5.07 crore. The company is actively expanding its national footprint, targeting 46% geographic coverage across India by March 2027.
Oct 20 2026 19:00:36
Aptus Pharma Ltd - 544529 - Board Meeting Intimation for Consideration Of Unaudited Financial Results For The Half Year Ended On September 30, 2026 And Closure Of Trading Window
Aptus Pharma board of directors will meet on 20 Oct 2026 for financial results. The board will also take on record the limited review report.
Oct 15 2026 23:29:52
Aptus Pharma Management
| Name | Position |
|---|---|
| Tejash Maheshchandra Hathi | Managing Director |
| Chetan Shantilal Lalseta | Non Executive Director |
Aptus Pharma Similar Stocks
Aptus Pharma FAQs
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in APPL
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
+ Free 1st Year AMC